SPCX enters the week with a sharp contradiction at its core — ten Wall Street desks initiated coverage yesterday with unanimous Buy-equivalent ratings, and the stock fell 6.8% the same session, extending a 12.5% weekly decline to $149.47.
The analyst wave is as bullish as initiations get. Deutsche Bank opened with a Buy and a $255 target. JP Morgan and RBC both came in Overweight and Outperform respectively at $225. BofA Securities initiated Buy at $235, and Bernstein went Outperform at $239. The consensus mean of $205 implies 37% upside from current levels — and that number excludes Raymond James, whose $800 target remains a significant outlier well beyond the cluster. Every other firm landed between $217 and $255. The formal consensus ratings tally stands at 19 buys and 6 outperforms, with no hold or sell ratings on record. That is a rare degree of Street alignment on a newly listed name. The problem is the stock has moved in precisely the opposite direction from what those targets imply, every single day since those initiations went live.
The borrow market tells its own story about where real-money positioning sits. Availability has tightened dramatically over the past three weeks — from above 500% in mid-June, when the lending pool was effectively unlimited, to just 40.7% now. That means for every share currently borrowed, only 0.4 shares remain available to lend. The move has been nearly continuous: availability was 115% on June 24, 86% on June 26, and has compressed through the 40s this week, touching its tightest point of the year on July 6 at 40.3%. Cost to borrow has risen in parallel, running near 1.4–1.5% after briefly spiking to 13.9% on June 15. Short positions themselves have been frozen at 23.3 million shares for every session on record — no new shorts added, none covered. The tightening availability therefore reflects existing borrowers holding positions as new demand for borrows competes for a shrinking pool, not an acceleration of fresh short selling.
Options positioning has edged more defensive as the stock has fallen. The put/call ratio has climbed from 0.82 on July 2 to 0.91 on July 7, close to its 52-week high of 1.06 reached on June 22 — the session that also marked the single sharpest spike in cost to borrow. A full 20-day z-score is unavailable given how recently the stock began trading, but the directional drift in the PCR is consistent with the broader cautious tilt. The ORTEX short score has nudged higher each session this week, reaching 50.5 — up from 48.9 on June 25 — though it remains in neutral territory and well below the 63.5 reading recorded on June 24, which appears to have been a data anomaly around the IPO period.
The bull case rests on Starlink subscriber growth, the Starship program's commercial launch cadence, and the xAI/Grok platform as an emerging profitability driver. Bears point to customer concentration, the cost and timeline risk of the Mars programme, and a PE multiple sitting near 20,000x — a figure that captures how early-stage the earnings base remains relative to the valuation the market is being asked to accept. The EV/EBITDA of 51x is more workable as a reference point, but it has compressed 7 points over the past week as the stock has fallen. Elon Musk holds 46% of shares, which concentrates both governance and sentiment risk in a single name. FMR added 83 million shares in the most recent reporting period, and BlackRock initiated a position of nearly 11 million shares — institutional flow that suggests passive and active buyers are stepping in even as the price falls.
The next hard catalyst is the August 6 earnings event. Between now and then, the rate at which availability continues to tighten — and whether short positions finally begin to move from their locked level — will be the clearest signal of whether the gap between the Street's $205–$255 target cluster and the $149 market price starts to close or widens further.
See the live data behind this article on ORTEX.
Open SPCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
